{"id":9782,"date":"2024-08-01T12:51:44","date_gmt":"2024-08-01T07:21:44","guid":{"rendered":"https:\/\/indianpharmanetwork.co.in\/medicines\/?post_type=product&p=9782"},"modified":"2024-11-12T10:59:09","modified_gmt":"2024-11-12T05:29:09","slug":"tecentriq-atezolizumab","status":"publish","type":"product","link":"https:\/\/indianpharmanetwork.co.in\/medicines\/product\/tecentriq-atezolizumab\/","title":{"rendered":"TECENTRIQ (atezolizumab) injection"},"content":{"rendered":"

Atezolizumab<\/strong>\u00a0is a programmed death-ligand 1 (PD-L1) blocking antibody indicated for the treatment of patients with locally advanced or metastatic urothelial carcinoma who are not eligible for cisplatin-containing chemotherapy, and whose tumors express PD-L1 (PD-L1 stained tumor-infiltrating immune cells [IC] covering \u2265 5% of the tumor area), or are not eligible for any platinum-containing chemotherapy regardless of level of tumor PD-L1 expression, or have disease progression during or following any platinum-containing chemotherapy, or within 12 months of neoadjuvant or adjuvant chemotherapy.<\/p>\n

How can 1 go about obtaining Atezolizumab?<\/h4>\n

If Tecentriq (Atezolizumab) are not yet approved or available in your area, you may request its price in India under a specific brand name through IPN.<\/strong> For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query.\u00a0To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) \/ +91 9811 747 774 (Mr. Neeraj).<\/strong><\/p>\n

Note:<\/strong><\/em>
\nWe are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient. Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India<\/a><\/strong>. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as\u00a0Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik,<\/strong>\u00a0and various other regions in India.<\/em><\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

Brand Name: Tecentriq Generic Name: (Atezolizumab)
\nTecentriq (Atezolizumab) is used to treat patients with locally advanced or metastatic urothelial carcinoma<\/h2>\n

TECENTRIQ<\/strong> is a programmed death-ligand 1 (PD-L1) blocking antibody indicated for the treatment of patients with locally advanced or metastatic urothelial carcinoma who are not eligible for cisplatin-containing chemotherapy, and whose tumors express PD-L1 (PD-L1 stained tumor-infiltrating immune cells [IC] covering \u2265 5% of the tumor area), or are not eligible for any platinum-containing chemotherapy regardless of level of tumor PD-L1 expression, or have disease progression during or following any platinum-containing chemotherapy, or within 12 months of neoadjuvant or adjuvant chemotherapy.<\/p>\n\n\n\n\n\n\n\n
Brand Name:<\/strong><\/td>\nTecentriq<\/td>\n<\/tr>\n
Generic Name:<\/strong><\/td>\nAtezolizumab<\/td>\n<\/tr>\n
Strength:<\/strong><\/td>\nInjection: 1200 mg\/20 mL (60 mg\/mL) solution in a single-dose vial.<\/td>\n<\/tr>\n
Manufacturer:<\/strong><\/td>\nGenentech<\/td>\n<\/tr>\n
Approved By:<\/strong><\/td>\nEMA, USFDA<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Source Details:\u00a0Patient Information<\/strong><\/a><\/p>\n

IPN, New Delhi can facilitate patient to import of \u201cTecentriq (Atezolizumab)\u201d<\/strong>\u00a0in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please\u00a0email IPN healthcare Support Team\u00a0<\/a>for Tecentriq (Atezolizumab)<\/strong>\u00a0price list or cost in India. on\u00a0Mr. Tarun:- +91 9891 296 838 \/ Mr. Neeraj:- +91 9811 747 774.<\/strong><\/em><\/p>\n","protected":false},"featured_media":10020,"template":"","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":""},"product_brand":[],"product_cat":[161,160],"product_tag":[],"class_list":{"0":"post-9782","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-breast-cancer","7":"product_cat-solid-tumors","9":"first","10":"instock","11":"shipping-taxable","12":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product\/9782","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/types\/product"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/media\/10020"}],"wp:attachment":[{"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/media?parent=9782"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product_brand?post=9782"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product_cat?post=9782"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product_tag?post=9782"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}